Kodiak Sciences Valuation

KOD Stock  USD 22.07  0.07  0.32%   
At this time, the firm appears to be undervalued. Kodiak Sciences secures a last-minute Real Value of $28.39 per share. The latest price of the firm is $22.07. Our model forecasts the value of Kodiak Sciences from analyzing the firm fundamentals such as Shares Owned By Insiders of 4.77 %, current valuation of 1.34 B, and Return On Equity of -2.08 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kodiak Sciences' valuation include:
Price Book
56.7659
Enterprise Value
1.3 B
Enterprise Value Ebitda
(0.12)
Undervalued
Today
22.07
Please note that Kodiak Sciences' price fluctuation is not too volatile at this time. Calculation of the real value of Kodiak Sciences is based on 3 months time horizon. Increasing Kodiak Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kodiak stock is determined by what a typical buyer is willing to pay for full or partial control of Kodiak Sciences. Since Kodiak Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kodiak Stock. However, Kodiak Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  22.07 Real  28.39 Target  35.5 Hype  22.22
The real value of Kodiak Stock, also known as its intrinsic value, is the underlying worth of Kodiak Sciences Company, which is reflected in its stock price. It is based on Kodiak Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kodiak Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
28.39
Real Value
33.42
Upside
Estimating the potential upside or downside of Kodiak Sciences helps investors to forecast how Kodiak stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kodiak Sciences more accurately as focusing exclusively on Kodiak Sciences' fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-1.15-0.93-0.78
Details
Hype
Prediction
LowEstimatedHigh
17.1922.2227.25
Details
6 Analysts
Consensus
LowTarget PriceHigh
32.3135.5039.41
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kodiak Sciences' intrinsic value based on its ongoing forecasts of Kodiak Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kodiak Sciences' closest peers. If more than one evaluation category is relevant for Kodiak Sciences we suggest using both methods to arrive at a better estimate.

Kodiak Sciences Cash

321.57 Million

Kodiak Sciences Total Value Analysis

Kodiak Sciences is now estimated to have company total value of 1.34 B with market capitalization of 1.35 B, debt of 70.34 M, and cash on hands of 597.88 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Kodiak Sciences fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.34 B
1.35 B
70.34 M
597.88 M

Kodiak Sciences Asset Utilization

One of the ways to look at asset utilization of Kodiak is to check how much profit was generated for every dollar of assets it reports. Kodiak Sciences secures a negative usage of assets of -0.47 %, losing $0.004721 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kodiak Sciences shows how discouraging it operates for each dollar spent on its assets.
 
Covid
 
Interest Hikes

Kodiak Sciences Profitability Analysis

Based on Kodiak Sciences' profitability indicators, Kodiak Sciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Kodiak Sciences' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2016-12-31
Previous Quarter
-54.3 M
Current Value
-61.5 M
Quarterly Volatility
28.3 M
 
Covid
 
Interest Hikes
The current year's Gross Profit is expected to grow to about (22.8 M)
For Kodiak Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kodiak Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kodiak Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kodiak Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kodiak Sciences over time as well as its relative position and ranking within its peers.

Kodiak Sciences Earnings per Share Projection vs Actual

The next projected EPS of Kodiak Sciences is estimated to be -0.931625 with future projections ranging from a low of -1.15385 to a high of -0.7825. Kodiak Sciences' most recent 12-month trailing earnings per share (EPS TTM) is at -4.12. Please be aware that the consensus of earnings estimates for Kodiak Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Kodiak Sciences is projected to generate -0.931625 in earnings per share on the 31st of December 2026. Kodiak Sciences earnings estimates show analyst consensus about projected Kodiak Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Kodiak Sciences' historical volatility. Many public companies, such as Kodiak Sciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Kodiak Sciences Earnings Estimation Breakdown

The calculation of Kodiak Sciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Kodiak Sciences is estimated to be -0.931625 with the future projection ranging from a low of -1.15385 to a high of -0.7825. Please be aware that this consensus of annual earnings estimates for Kodiak Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-1.15
Lowest
Expected EPS
-0.931625
-0.78
Highest

Kodiak Sciences Earnings Projection Consensus

Suppose the current estimates of Kodiak Sciences' value are higher than the current market price of the Kodiak Sciences stock. In this case, investors may conclude that Kodiak Sciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Kodiak Sciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2026Current EPS (TTM)
779.37%
0.0
-0.931625
-4.12

Kodiak Sciences Ownership Allocation

Kodiak Sciences maintains a total of 61.05 Million outstanding shares. The majority of Kodiak Sciences outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kodiak Sciences to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kodiak Sciences. Please pay attention to any change in the institutional holdings of Kodiak Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Kodiak Sciences Profitability Analysis

Reported Net Loss for the year was (176.21 M) with profit before taxes, overhead, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kodiak Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kodiak Sciences and how it compares across the competition.

About Kodiak Sciences Valuation

The stock valuation mechanism determines Kodiak Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Kodiak Sciences. We calculate exposure to Kodiak Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kodiak Sciences's related companies.
Last ReportedProjected for Next Year
Gross Profit-24 M-22.8 M

Kodiak Sciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Kodiak Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kodiak we look at many different elements of the entity such as Kodiak's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kodiak Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kodiak Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kodiak Sciences' worth.

Complementary Tools for Kodiak Stock analysis

When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities